Journal
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Volume 46, Issue 1, Pages 3-16Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/ijmm.2020.4596
Keywords
SARS-COV-2; epidemiology; pandemic; public health; vaccines; immunization policy and strategies; clinical trials
Categories
Ask authors/readers for more resources
In the current context of the pandemic triggered by SARS-COV-2, the immunization of the population through vaccination is recognized as a public health priority. In the case of SARS-COV-2, the genetic sequencing was done quickly, in one month. Since then, worldwide research has focused on obtaining a vaccine. This has a major economic impact because new technological platforms and advanced genetic engineering procedures are required to obtain a COVID-19 vaccine. The most difficult scientific challenge for this future vaccine obtained in the laboratory is the proof of clinical safety and efficacy. The biggest challenge of manufacturing is the construction and validation of production platforms capable of making the vaccine on a large scale.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available